Rising Incidence Of Infectious Diseases Fuels Growth In Molecular Diagnostic Devices Market Driving Market Acceleration in the Molecular Diagnostics Devices And Equipment Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Molecular Diagnostics Devices And Equipment Industry Market Size Be by 2025?
The market size for molecular diagnostic devices and equipment has seen a significant increase in the past few years. The market, which was valued at $17.58 billion in 2024, is projected to reach $19.01 billion in 2025, growing at a compound annual growth rate (CAGR) of 8.1%. Factors such as increased funding, growth in healthcare spending, economic development in upcoming markets, swift advancements in technology, the emergence of new pathogenic diseases, and a fast-growing elderly population have all contributed to this historical growth.

What's the Long-Term Growth Forecast for the Molecular Diagnostics Devices And Equipment Market Size Through 2029?
The market for molecular diagnostics devices and equipment is anticipated to experience significant expansion in the coming years, with its value expected to reach $24.77 billion in 2029, reflecting a compound annual growth rate (CAGR) of 6.8%. This anticipated growth in the forecast period is linked to the swift increase in bacterial and viral epidemics, an aging populace, enhanced healthcare accessibility, a rise in chronic illness prevalence, and escalated demand for molecular diagnostic tools and equipment amid the COVID-19 pandemic. Key trends projected for the forecast period encompass automation in molecular diagnostics, the application of artificial intelligence, heightened demand for molecular diagnostic apparatus in researching rare conditions, the increasing use of big data, the application of next-generation sequencing for newborn screening, and point-of-care molecular diagnostics (POC mdx).

View the full report here:
https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

What Are the Key Growth Drivers Fueling the Molecular Diagnostics Devices And Equipment Market Expansion?
The prevalence of infectious diseases is projected to fuel the expansion of the molecular diagnostic devices and equipment market in the future. Infectious diseases are illnesses induced by harmful microorganisms, including bacteria, viruses, fungi, or parasites, and can be passed from person to person or from animals to humans. Antimicrobial resistance, globalization and travel, urbanization, socioeconomic differences, and an aging population are all contributing to the surge of infectious diseases. Molecular diagnostic devices and equipment play a crucial role in the identification and control of infectious diseases. For example, in March 2023, the Office for National Statistics, a UK government department, reported that in the week ending 17th March 2023, there were 619 COVID-19 related fatalities in the UK, an increase from 605 the previous week. In that week, COVID-19 deaths accounted for 4.5% of all deaths in the UK, a minor decrease from 4.6% the week before. As such, the increasing prevalence of infectious diseases is propelling the molecular diagnostic devices and equipment market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp

What Are the Key Trends Driving Molecular Diagnostics Devices And Equipment Market Growth?
Leading companies in the molecular diagnostic market are prioritizing the development of automated solutions for devices and equipment integral to molecular diagnostic operations. This automation will enhance the effectiveness and reliability of the entire diagnostic process. The digitization of these procedures provides dependable and efficient test outputs that surpass manual tests performed by multiple experts. The industry's key players are leveraging nanotechnology-based Oral Fluid Nano Sensor Test (OFNASET), a test utilizing a microfluidic-based nanosensor to identify oral cancer biomarkers in saliva. To align with the automation and precision trend, Roche has developed cobas connection modules (CCM), aimed at augmenting scalability and sample-flow productivity by enabling samples to be automatically transferred between varying systems and devices, creating an entirely automated workflow.

How Is the Molecular Diagnostics Devices And Equipment Market Segmented?
The molecular diagnostics devices and equipment market covered in this report is segmented -

1) By Product: Instruments, Reagents And Consumables, Software
2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies
3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications
4) By End User: Diagnostic laboratories, Hospitals, Other End Users

Subsegments:
1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays
2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials
3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2595&type=smp

Which Companies Are Leading the Charge in Molecular Diagnostics Devices And Equipment Market Innovation?
Major companies operating in the molecular diagnostics devices and equipment market include F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di'an Diagnostics Technology Co. Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, BGI-Shenzhen, OriGene Technologies, Bayer AG, Johnson & Johnson, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, Interlabservis, GeneMe, TestLine, Clinical Diagnostics s.r.o, Hologic Inc., Illumina Inc., Novartis AG, Cepheid Inc., Admera Health, Agilent technologies Inc., AutoGenomics, Bio-Red Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd.

Which Regions Are Leading the Global Molecular Diagnostics Devices And Equipment Market in Revenue?
Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2024. Western Europe was the second largest market in molecular diagnostics devices (or) equipment market. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2595

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.